Consolidated Statement Of Comprehensive Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7610649

Concept 2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
131,775,000,000 JPY
JPY
131,775,000,000 JPY
131,775,000,000 JPY
JPY
JPY
47,411,000,000 JPY
JPY
47,411,000,000 JPY
47,411,000,000 JPY
JPY
JPY
Other comprehensive income
Items that will not be reclassified to profit or loss
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income
-5,000,000 JPY
-107,000,000 JPY
Total of items that will not be reclassified to profit or loss
-5,000,000 JPY
-107,000,000 JPY
Items that may be reclassified to profit or loss
Exchange differences on translation of foreign operations
2,945,000,000 JPY
1,704,000,000 JPY
Effective portion of cash flow hedges
-6,889,000,000 JPY
2,675,000,000 JPY
Total of items that may be reclassified to profit or loss
-3,948,000,000 JPY
4,384,000,000 JPY
Other comprehensive income
-3,953,000,000 JPY
4,277,000,000 JPY
Comprehensive income
127,822,000,000 JPY
-3,953,000,000 JPY
127,822,000,000 JPY
131,775,000,000 JPY
JPY
JPY
51,688,000,000 JPY
4,277,000,000 JPY
51,688,000,000 JPY
47,411,000,000 JPY
JPY
JPY
Comprehensive income attributable to
Owners of parent
127,822,000,000 JPY
51,688,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.